Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
16–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has a current diagnosis of symptomatic PAH
Has 6MWT distances from 150 to 450 meters and distance
You may not be if
Previous exposure to an endothelin receptor antagonist
Has uncontrolled systemic hypertension as evidenced by sitting systolic blood pressure \>160 mm Hg or sitting diastolic blood pressure \>100 mm Hg at Screening.
Has hypotension defined as systolic arterial pressure \<90 mm Hg after sitting for 5 minutes at Screening.
Clareo Health | A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients
